R. Pal

发表

Membrane bound Indian clade C HIV-1 envelope antigen induces antibodies to diverse and conserved epitopes upon DNA prime/protein boost in rabbits.

Veena P Menon, Sneha Priya Rangasamy, Priyanka Dhopeshwarkar, 2016, Vaccine.

Antibody Fab‐Fc properties outperform titer in predictive models of SIV vaccine‐induced protection

J. Weiner, C. Bailey-Kellogg, D. Montefiori, 2019, Molecular systems biology.

Rapid SIV Env-specific mucosal and serum antibody induction augments cellular immunity in protecting immunized, elite-controller macaques against high dose heterologous SIV challenge.

D. Montefiori, M. Roederer, M. Robert-Guroff, 2011, Virology.

Synergistic inhibition of R5 HIV-1 by maraviroc and CCR5 antibody HGS004 in primary cells: implications for treatment and prevention

A. Heredia, M. Reitz, N. Le, 2011, AIDS.

Characterization of a SHIV162P3 variant evolved in an infected rhesus macaque with persistent plasma viremia.

R. Pal, H. Chung, J. Suschak, 2010, Virus research.

Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates

B. Korber, D. Montefiori, O. Yang, 2015, Journal of Virology.

Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition

F. Barrenäs, D. Montefiori, S. Santra, 2020, PLoS pathogens.

Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1

M. Reitz, R. Gallo, R. Pal, 1995, Journal of virology.

Two-Year Follow-Up of Macaques Developing Intermittent Control of the Human Immunodeficiency Virus Homolog Simian Immunodeficiency Virus SIVmac251 in the Chronic Phase of Infection

M. Biffoni, D. Montefiori, E. Arts, 2015, Journal of Virology.

Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E.

J. Mascola, Shixia Wang, Shan Lu, 2006, Virology.

In vitro activity of cysteamine against SARS-CoV-2 variants

M. G. Ferrari, R. Pal, J. Thoene, 2021, bioRxiv.

Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope

D. Montefiori, N. Letvin, R. Pal, 2008, AIDS.

Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers.

S. Green, A. Rothman, F. Ennis, 2008, Vaccine.

A Replication-Competent Adenovirus-Human Immunodeficiency Virus (Ad-HIV) tat and Ad-HIV env Priming/Tat and Envelope Protein Boosting Regimen Elicits Enhanced Protective Efficacy against Simian/Human Immunodeficiency Virus SHIV89.6P Challenge in Rhesus Macaques

D. Montefiori, N. Letvin, D. Venzon, 2007, Journal of Virology.

Crosslinked HIV-1 envelope–CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques

D. Montefiori, R. Pal, A. Devico, 2002, Proceedings of the National Academy of Sciences of the United States of America.

HIV-1 prophylactic vaccine comprised of topical DermaVir prime and protein boost elicits cellular immune responses and controls pathogenic R5 SHIV162P3.

J. Lisziewicz, F. Lori, M. G. Ferrari, 2007, Virology.

Virological and molecular characterization of a simian human immunodeficiency virus (SHIV) encoding the envelope and reverse transcriptase genes from HIV-1.

Bin Li, R. Pal, J. Mcnicholl, 2012, Virology.

Characterization of vaginal transmission of a simian human immunodeficiency virus (SHIV) encoding the reverse transcriptase gene from HIV-1 in Chinese rhesus macaques.

R. Pal, J. Nuttall, J. Romano, 2009, Virology.

Evaluation of -2 RANTES vaginal microbicide formulations in a nonhuman primate simian/human immunodeficiency virus (SHIV) challenge model.

M. Reitz, R. Gallo, R. Pal, 2007, AIDS research and human retroviruses.

Impairment of Gag-Speciﬁc CD8 (cid:1) T-Cell Function in Mucosal and Systemic Compartments of Simian Immunodeﬁciency Virus mac251- and Simian-Human Immunodeﬁciency Virus KU2-Infected Macaques

Todd M. Allen, I. M. Belyakov, J. Berzofsky, 2001 .

The safety and tolerability of an HIV-1 DNA prime-protein boost vaccine (DP6-001) in healthy adult volunteers.

S. Green, A. Rothman, Shixia Wang, 2008, Vaccine.

Inhibition of HIV-1 Infection by the β-Chemokine MDC

A. Garzino-Demo, R. Gallo, R. Pal, 1997 .

Phosphorothioate oligodeoxycytidine interferes with binding of HIV-1 gp120 to CD4.

L. Neckers, R. Pal, C. Stein, 1991, Journal of acquired immune deficiency syndromes.

Characterization of a simian human immunodeficiency virus encoding the envelope gene from the CCR5-tropic HIV-1 Ba-L.

Andrew Gibson, M. Reitz, J. Foulke, 2003, Journal of acquired immune deficiency syndromes.

Comparative study of Tat vaccine regimens in Mauritian cynomolgus and Indian rhesus macaques: influence of Mauritian MHC haplotypes on susceptibility/resistance to SHIV(89.6P) infection.

D. O’Connor, D. Venzon, M. Robert-Guroff, 2008, Vaccine.

Monoclonal antibodies to HTLV-III451 gp41: delineation of an immunoreactive conserved epitope in the transmembrane region of divergent isolates of HIV-1.

R. Gallo, R. Pal, P. Lusso, 1989, AIDS research and human retroviruses.

Effect of Evans blue and trypan blue on syncytia formation and infectivity of human immunodeficiency virus type I and type II in vitro.

R. Pal, C. Stein, M. Sarngadharan, 1991, AIDS research and human retroviruses.

Inhibition of HIV-1 infection by the beta-chemokine MDC.

M. Brown, A. Garzino-Demo, R. Gallo, 1997, Science.

ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type

D. Montefiori, D. Venzon, G. Alter, 2019, PLoS pathogens.

Polyvalent DNA prime and envelope protein boost HIV‐1 vaccine elicits humoral and cellular responses and controls plasma viremia in rhesus macaques following rectal challenge with an R5 SHIV isolate

J. Mascola, D. Montefiori, Shixia Wang, 2005, Journal of medical primatology.

Characterization of protective immune response elicited by a trimeric envelope protein from an Indian clade C HIV‐1 isolate in rhesus macaques

D. Montefiori, Veena P Menon, C. Labranche, 2015, Journal of medical primatology.

Definitive toxicology and biodistribution study of a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 (HIV-1) vaccine in rabbits.

Shixia Wang, Shan Lu, R. Pal, 2006, Vaccine.

Myristoylation of gag proteins of HIV-1 plays an important role in virus assembly.

E. Tschachler, M. Reitz, R. Gallo, 1990, AIDS research and human retroviruses.

Processing of the structural proteins of human immunodeficiency virus type 1 in the presence of monensin and cerulenin.

R. Gallo, R. Pal, M. Sarngadharan, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Antibodies to CD4-induced sites in HIV gp120 correlate with the control of SHIV challenge in macaques vaccinated with subunit immunogens

R. Gallo, R. Pal, G. Lewis, 2007, Proceedings of the National Academy of Sciences.

Brefeldin A inhibits the processing and secretion of envelope glycoproteins of human immunodeficiency virus type 1.

R. Pal, A. Takatsuki, M. Sarngadharan, 1991, AIDS research and human retroviruses.

Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1.

R. Pal, M. Sarngadharan, G. Hoke, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Processing and secretion of envelope glycoproteins of human immunodeficiency virus type 1 in the presence of trimming glucosidase inhibitor deoxynojirimycin.

R. Pal, M. Sarngadharan, V. Kalyanaraman, 1989, Intervirology.

Mode of action of 5'-linked cholesteryl phosphorothioate oligodeoxynucleotides in inhibiting syncytia formation and infection by HIV-1 and HIV-2 in vitro.

R. Letsinger, R. Pal, M. Sarngadharan, 1991, Biochemistry.

Induction of mucosal and systemic antibody and T-cell responses following prime–boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations

N. Petrovsky, M. G. Ferrari, R. Pal, 2011, The Journal of general virology.

Increased immune responses in rhesus macaques by DNA vaccination combined with electroporation.

R. Pal, G. Pavlakis, B. Felber, 2008, Vaccine.

Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIVmac251 Rectal Challenge

D. Montefiori, D. Venzon, M. G. Ferrari, 2015, PLoS pathogens.

Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa.

J. Berzofsky, R. Pal, M. Moniuszko, 2006, Blood.

Delineation of immunoreactive, conserved regions in the external glycoprotein of the human immunodeficiency virus type 1.

R. Gallo, R. Pal, C. Boyer, 1992, AIDS research and human retroviruses.

ALVAC-SIV-gag-pol-env-Based Vaccination and Macaque Major Histocompatibility Complex Class I (A*01) Delay Simian Immunodeficiency Virus SIVmac-Induced Immunodeficiency

D. Montefiori, S. Santra, N. Letvin, 2002, Journal of Virology.

Systemic Immunization with an ALVAC-HIV-1/Protein Boost Vaccine Strategy Protects Rhesus Macaques from CD4+ T-Cell Loss and Reduces both Systemic and Mucosal Simian-Human Immunodeficiency Virus SHIVKU2 RNA Levels

J. Berzofsky, D. Montefiori, S. Santra, 2006, Journal of Virology.

Correlation between viral RNA levels but not immune responses in plasma and tissues of macaques with long-standing SIVmac251 infection.

Steven Wolinsky, D. Venzon, D. Bogdan, 2005, Virology.

Infection of monkeys by simian-human immunodeficiency viruses with transmitted/founder clade C HIV-1 envelopes.

J. Sodroski, B. Haynes, D. Burton, 2015, Virology.

Derivation and Characterization of Pathogenic Transmitted/Founder Molecular Clones from Simian Immunodeficiency Virus SIVsmE660 and SIVmac251 following Mucosal Infection

G. Learn, J. Lifson, G. Shaw, 2016, Journal of Virology.

Comparative Characterization of Transfection- and Infection-Derived Simian Immunodeficiency Virus Challenge Stocks for In Vivo Nonhuman Primate Studies

Christopher J. Miller, David H. O'Connor, Brandon F. Keele, 2013, Journal of Virology.

Development of real‐time PCR for quantitation of simian immunodeficiency virus 2‐LTR circles

M. Kuroda, R. Pal, Woong-Ki Kim, 2016, Journal of medical primatology.

Impairment of Gag-Specific CD8+ T-Cell Function in Mucosal and Systemic Compartments of Simian Immunodeficiency Virus mac251- and Simian-Human Immunodeficiency Virus KU2-Infected Macaques

Todd M. Allen, J. Berzofsky, D. Watkins, 2001, Journal of Virology.

Macaques Immunodeficiency Virus KU 2-Infected Virus mac 251-and Simian-Human Compartments of Simian Immunodeficiency Function in Mucosal and Systemic T-Cell + Impairment of Gag-Specific CD 8

Todd M. Allen, J. Berzofsky, D. Watkins, 2001 .

Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus

Brigitte E. Sanders-Beer, D. Hamer, D. Venzon, 2011, Mucosal Immunology.

Novel Strategy To Adapt Simian-Human Immunodeficiency Virus E1 Carrying env from an RV144 Volunteer to Rhesus Macaques: Coreceptor Switch and Final Recovery of a Pathogenic Virus with Exclusive R5 Tropism

Jerome H. Kim, D. Montefiori, M. Robb, 2018, Journal of Virology.

Transcription profiling of CD4+ T cells in rhesus macaques that infected with simian‐human immunodeficiency virus and re‐challenged with SIVmac251

C. Pise-Masison, M. Radonovich, R. Pal, 2015, Journal of medical primatology.

Lateral diffusion of CD4 on the surface of a human neoplastic T‐cell line probed with a fluorescent derivative of the envelope glycoprotein (gp120) of human immunodeficiency virus type 1 (HIV‐1)

M. Edidin, R. Pal, M. Sarngadharan, 1991, Journal of cellular physiology.

Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection

D. Montefiori, R. Zagursky, C. Labranche, 2015, Proceedings of the National Academy of Sciences.

Impact of antibody quality and anamnestic response on viremia control post-challenge in a combined Tat/Env vaccine regimen in rhesus macaques.

D. Montefiori, D. Venzon, Stanley Aladi, 2013, Virology.

Replicating Adenovirus-Simian Immunodeficiency Virus (SIV) Recombinant Priming and Envelope Protein Boosting Elicits Localized, Mucosal IgA Immunity in Rhesus Macaques Correlated with Delayed Acquisition following a Repeated Low-Dose Rectal SIVmac251 Challenge

D. Montefiori, D. Venzon, B. Keele, 2012, Journal of Virology.

Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime/protein boost vaccine regimen against a second SIVmac251 rectal challenge: role of SIV-specific CD8+ T cell responses.

D. Venzon, M. Robert-Guroff, R. Pal, 2006, Virology.

Correction: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type

D. Montefiori, D. Venzon, G. Alter, 2019, PLoS pathogens.

Molecular methods for evaluation of virological status of nonhuman primates challenged with simian immunodeficiency or simian-human immunodeficiency viruses.

R. Pal, H. Chung, P. Markham, 2010, Journal of virological methods.

Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype.

J. Mascola, D. Montefiori, Shixia Wang, 2006, Virology.

A unique human immunodeficiency virus culture secreting soluble gp160.

R. Gallo, R. Pal, M. Sarngadharan, 1988, AIDS research and human retroviruses.

Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine.

Shixia Wang, Shan Lu, R. Pal, 2006, Virology.

AIDS-viral dissemination from mucosa Impact of vaccine-induced mucosal high avidity CD8+ CTL in delay of

J. Berzofsky, R. Pal, M. Moniuszko, 2013 .

High Frequency of Virus-Specific CD8+ T Cells in the Central Nervous System of Macaques Chronically Infected with Simian Immunodeficiency Virus SIVmac251

Charles R. Brown, R. Pal, M. Moniuszko, 2003, Journal of Virology.

Differential pathogenicity of SHIVSF162 P4 infection in pig‐tailed and rhesus macaques

L. Stamatatos, Z. Kraft, Shiu-Lok Hu, 2008, Journal of medical primatology.

Cellular gene expression profiles in rhesus macaques challenged mucosally with a pathogenic R5 tropic simian human immunodeficiency virus isolate.

J. Brady, C. Pise-Masison, M. Radonovich, 2008, Viral immunology.

Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage.

E. Tschachler, M. Reitz, R. Gallo, 1990, Virology.

Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers.

S. Green, A. Rothman, F. Ennis, 2008, Vaccine.

DNA prime/protein boost vaccination elicits robust humoral response in rhesus macaques using oligomeric simian immunodeficiency virus envelope and Advax delta inulin adjuvant.

N. Petrovsky, D. Montefiori, C. Labranche, 2017, The Journal of general virology.

Immune targeting of PD-1(hi) expressing cells during and after antiretroviral therapy in SIV-infected rhesus macaques.

J. Berzofsky, D. Venzon, S. Langermann, 2013, Virology.

Antibodies with High Avidity to the gp120 Envelope Protein in Protection from Simian Immunodeficiency Virus SIVmac251 Acquisition in an Immunization Regimen That Mimics the RV-144 Thai Trial

Jerome H. Kim, D. Montefiori, D. Stablein, 2012, Journal of Virology.

Oral delivery of replication-competent adenovirus vectors is well tolerated by SIV- and SHIV-infected rhesus macaques.

W. Alvord, M. Robert-Guroff, R. Pal, 2006, Vaccine.

An HIV gp120-CD4 Immunogen Does Not Elicit Autoimmune Antibody Responses in Cynomolgus Macaques

R. Gallo, R. Pal, G. Lewis, 2016, Clinical and Vaccine Immunology.

Early SIV Dissemination After Intrarectal SIVmac251 Challenge Was Associated With Proliferating Virus-Susceptible Cells in the Colorectum

J. Berzofsky, D. Venzon, R. Pal, 2016, Journal of acquired immune deficiency syndromes.

Therapeutic envelope vaccination in combination with antiretroviral therapy temporarily rescues SIV‐specific CD4+ T‐cell‐dependent natural killer cell effector responses in chronically infected rhesus macaques

M. Robert-Guroff, R. Pal, D. Vargas-Inchaustegui, 2015, Immunology.

Antigenicity and Immunogenicity of a Trimeric Envelope Protein from an Indian Clade C HIV-1 Isolate*

D. Montefiori, C. Labranche, R. Pal, 2015, The Journal of Biological Chemistry.

Detection of HIV-1 infection in vitro using NASBA: an isothermal RNA amplification technique.

R. Pal, M. Sarngadharan, J W Romano, 1995, Journal of virological methods.

Immunodeficiency Virus SIVmac 251 Macaques Chronically Infected with Simian Cells in the Central Nervous System of T + High Frequency of Virus-Specific CD 8

Charles R. Brown, R. Pal, M. Moniuszko, 2003 .

Immunogenicity of HIV Virus-Like Particles in Rhesus Macaques by Intranasal Administration

F. Buonaguro, L. Buonaguro, R. Pal, 2012, Clinical and Vaccine Immunology.

HIV-1 Env vaccine comprised of electroporated DNA and protein co-administered with Talabostat.

R. Pal, R. Draghia‐Akli, Ruxandra Draghia-Akli, 2008, Biochemical and biophysical research communications.

Persistent antibody and T cell responses induced by HIV-1 DNA vaccine delivered by electroporation.

R. Pal, R. Draghia‐Akli, P. Markham, 2008, Biochemical and biophysical research communications.

Conformational perturbation of the envelope glycoprotein gp120 of human immunodeficiency virus type 1 by soluble CD4 and the lectin succinyl Con A.

R. Pal, M. Sarngadharan, A. Devico, 1993, Virology.

Simian Immunodeficiency Virus Epitopes in Subdominant CTL Specific for Dominant and Recombinant Canarypox Vaccine-Elicited

J. Schmitz, M. Kuroda, S. Santra, 2013 .

Recombinant Canarypox Vaccine-Elicited CTL Specific for Dominant and Subdominant Simian Immunodeficiency Virus Epitopes in Rhesus Monkeys1

J. Schmitz, M. Kuroda, S. Santra, 2002, The Journal of Immunology.